Singapore markets open in 7 hours 37 minutes

AdaptHealth Corp. (AHCO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
9.83-0.01 (-0.10%)
As of 01:20PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 1.31B
Enterprise value 3.53B
Trailing P/E N/A
Forward P/E 12.02
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.41
Price/book (mrq)0.90
Enterprise value/revenue 1.10
Enterprise value/EBITDA -16.74

Trading information

Stock price history

Beta (5Y monthly) 1.11
52-week change 3-16.33%
S&P500 52-week change 323.42%
52-week high 315.37
52-week low 36.37
50-day moving average 39.50
200-day moving average 39.55

Share statistics

Avg vol (3-month) 31.13M
Avg vol (10-day) 3853.49k
Shares outstanding 5132.91M
Implied shares outstanding 6132.91M
Float 875.51M
% held by insiders 117.43%
% held by institutions 187.11%
Shares short (28 Mar 2024) 48.21M
Short ratio (28 Mar 2024) 46.98
Short % of float (28 Mar 2024) 47.91%
Short % of shares outstanding (28 Mar 2024) 46.18%
Shares short (prior month 29 Feb 2024) 49.03M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -21.21%
Operating margin (ttm)12.15%

Management effectiveness

Return on assets (ttm)3.34%
Return on equity (ttm)-37.24%

Income statement

Revenue (ttm)3.2B
Revenue per share (ttm)23.85
Quarterly revenue growth (yoy)10.00%
Gross profit (ttm)N/A
EBITDA 643.11M
Net income avi to common (ttm)-678.89M
Diluted EPS (ttm)-5.31
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)81.61M
Total cash per share (mrq)0.61
Total debt (mrq)2.29B
Total debt/equity (mrq)156.45%
Current ratio (mrq)1.21
Book value per share (mrq)11.33

Cash flow statement

Operating cash flow (ttm)480.67M
Levered free cash flow (ttm)176.41M